Alpha-1 Antitrypsin Deficiency Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Study Comparing Weekly Intravenous Administration of OctaAlpha1 With a Marketed Preparation Glassia ® in Subjects With Alpha-1-antitrypsin Deficiency
Condition: Alpha 1-Antitrypsin Deficiency Interventions: Drug: OctaAlpha1; Drug: Glassia Sponsor: Octapharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2017 Category: Research Source Type: clinical trials
